MedPath

DESTINY PHARMA PLC

DESTINY PHARMA PLC logo
🇬🇧United Kingdom
Ownership
Public
Established
1996-01-01
Employees
15
Market Cap
-
Website
http://www.destinypharma.com

Clinical Trials

3

Active:0
Completed:3

Trial Phases

3 Phases

Phase 1:1
Phase 2:1
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (33.3%)
Phase 2
1 (33.3%)
Phase 4
1 (33.3%)

Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

Phase 2
Completed
Conditions
Staphylococcal Infections
Surgical Site Infection
Interventions
Drug: Placebo
First Posted Date
2019-04-16
Last Posted Date
2023-10-16
Lead Sponsor
Destiny Pharma Plc
Target Recruit Count
124
Registration Number
NCT03915470
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

🇺🇸

Snake River Research, PLLC, Pocatello, Idaho, United States

🇺🇸

MercyOne Iowa Heart Center, Des Moines, Iowa, United States

and more 18 locations

Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

Phase 4
Completed
Conditions
Staphylococcal Infection
Interventions
First Posted Date
2014-11-06
Last Posted Date
2016-03-01
Lead Sponsor
Destiny Pharma Plc
Target Recruit Count
12
Registration Number
NCT02284555
Locations
🇬🇧

Simbec Reseach Ltd, Wales, United Kingdom

Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects

Phase 1
Completed
Conditions
Staphylococcus Aureus Infection
Interventions
Drug: XF-73 nasal gel
Drug: Placebo nasal gel
Other: Chlorhexidine gluconate 2% topical cloths
First Posted Date
2014-11-04
Last Posted Date
2016-10-07
Lead Sponsor
Destiny Pharma Plc
Target Recruit Count
60
Registration Number
NCT02282605
Locations
🇬🇧

Quintiles Drug Research Unit, London, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.